Smith & Nephew plc ADRSN
Price$26.58Intrinsic value$109.49312% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $109.49median of 6 methods · middle span $82-$164based on filings through 31 Dec 2025
Market Price $26.58Price as of 1 Oct 2026
Margin of Safety +311.9%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 9.1% (near-term consensus, capped) · years 2–5: 10.1%/yr (balance of the path).9.9% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 68.7%Yr 77.3%Yr 85.9%Yr 94.5%Yr 103.1%
10.1% → 3.1%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.1%Yr 123.1%Yr 133.1%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.1% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)3.1%
Discount rate (cost of equity) 8.1%
Volatility vs market (adjusted beta)0.71

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetSmith & Nephew plc ADRSNHealth Care
Valuation
P/E—
P/S2.4×
P/B4.6×
EV / Revenue3.0×
EV / EBITDA10.2×
Profitability
Gross margin68.0%
Operating margin12.9%
Net margin13.1%
FCF margin17.6%
Returns
ROE11.8%
ROA6.0%
ROIC8.0%
Growth
Revenue growth (YoY)-18.0%
5-yr fwd EPS growth9.9%
Financial strength
Debt / Equity0.59×
Current ratio2.57×
Altman Z-Score—
Interest coverage—
Dividend yield2.3%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.